Investment analysts at StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a research note issued on Tuesday. The firm set a “sell” rating on the stock.
Oragenics Trading Up 18.9 %
NYSE:OGEN opened at $0.41 on Tuesday. The firm’s fifty day simple moving average is $0.34 and its 200 day simple moving average is $0.66. Oragenics has a twelve month low of $0.25 and a twelve month high of $6.42. The firm has a market capitalization of $5.01 million, a price-to-earnings ratio of -0.06 and a beta of 0.40.
Oragenics Company Profile
Featured Stories
- Five stocks we like better than Oragenics
- 10 Best Airline Stocks to Buy
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Dividend Capture Strategy: What You Need to Know
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Breakout Stocks: What They Are and How to Identify Them
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.
